USE OF A SELECTIVE OXYTOCIN RECEPTOR ANTAGONIST IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF PREMATURE EJACULATION, AN ASSAY METHOD FOR IDENTIFYING SUCH AGONISTS AND PHARMACEUTICAL COMPOSITIONS CONSISTING OF ONE OR MORE OF SAID ANTAGONISTS AND ONE OR MORE PDEIS

摘要

A composition comprising a selective oxytocin antagonist for use in the treatment and/or prevention of a male ejaculatory disorder; which selective oxytocin antagonist is optionally admixed witha a pharmaceutically acceptable carrier, diluent or excipient.